Mintaka Foundation for Medical Research

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

By volume: HIV Research and Treatment, Reproductive tract infections research, HIV/AIDS drug development and treatment and Immune Cell Function and Interaction.

1. 1 HIV Research and Treatment Virology 1 works
2. 2 Reproductive tract infections research Microbiology 0 works
3. 3 HIV/AIDS drug development and treatment Infectious Diseases 0 works
4. 4 Immune Cell Function and Interaction Immunology 0 works
5. 5 Herpesvirus Infections and Treatments Epidemiology 0 works
6. 6 HIV/AIDS Research and Interventions Infectious Diseases 0 works
7. 7 Immunotherapy and Immune Responses Immunology 0 works
8. 8 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
9. 9 Quantum, superfluid, helium dynamics Atomic and Molecular Physics, and Optics 0 works
10. 10 Microencapsulation and Drying Processes Food Science 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 59% lower than in 2013–2017.

• L.A.C. (Switzerland)
• Genkyotex (Switzerland)
• Addex Therapeutics (Switzerland)
• ObsEva (Switzerland)
• EspeRare Foundation
• Spineart (Switzerland)